Recombinant Human PSMA Protein(Fc Tag) (PDMH100295)
 
                        For research use only.
| Synonyms | GCP, GIG, Folate hydrolase, Glutamate carboxypeptidase, NAALAD, FGCP, FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA, mGCP, FOLH1, Cell growth-inhibiting gene 27 protein, Folate hydrolase 1, Glutamate carboxypeptidase 2, NAALADase I, N-acetylated alpha-linked acidic dipeptidase 1|cell growth-inhibiting protein 27|folate hydrolase 1|folylpoly-gamma-glutamate carboxypep, GIG27, FGCP, FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA, mGCP, FOLH1 | 
| Species | Human | 
| Expression Host | Mammalian | 
| Sequence | Lys44-Ala750 | 
| Accession | Q04609 | 
| Calculated Molecular Weight | 102.6 kDa | 
| Observed Molecular Weight | 100-110 kDa | 
| Tag | C-Fc | 
| Bio-activity | Not validated for activity | 
| Form | Lyophilized powder | 
| Purity | > 90% as determined by reducing SDS-PAGE. | 
| Endotoxin | < 1.0 EU/mg of the protein as determined by the LAL method | 
| Storage | Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months. | 
| Shipping | This product is provided as lyophilized powder which is shipped with ice packs. | 
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with 5% Trehalose and 5% Mannitol. | 
| Reconstitution | It is recommended that sterile water be added to the vial to prepare a stock solution of 0.5 mg/mL. Concentration is measured by UV-Vis. | 
| Background | Glutamate carboxypeptidase 2 , also known as Glutamate carboxypeptidase II , Membrane glutamate carboxypeptidase , Prostate-specific membrane antigen , GCPII , PSMA , FOLH1 , and NAALAD1 , is a single-pass type II membrane protein which belongs to thepeptidase M28 family and M28B subfamily. FOLH1 is highly expressed in prostate epithelium. It is detected in urinary bladder , kidney , testis , ovary , fallopian tube , breast , adrenal gland , liver , esophagus , stomach , small intestine , colon , brain (at protein level) , and the capillary endothelium of a variety of tumors. FOLH1 has both folate hydrolase and N-acetylated alpha linked acidic dipeptidase (NAALADase) activity. It has a preference for tri-alpha-glutamate peptides. Genetic variation in FOLH1 may be associated with low folate levels and consequent hyperhomocysteinemia. This condition can result in increased risk of cardiovascular disease , neural tube defects , and cognitive deficits. FOLH1 also shows a promising role in directed imaging and therapy of recurrent or metastatic disease. | 
Other Clones
{{antibodyDetailsPage.numTotal}} Results
- 
                                    
                                    
                                    {{item.title}}
                                    Citations ({{item.publications_count}}) Manual MSDS Cat.No.:{{item.cat}} {{index}} {{goods_show_value}} 
Other Formats
{{formatDetailsPage.numTotal}} Results
- 
                                    
                                    
                                    {{item.title}}
                                    Citations ({{item.publications_count}}) Manual MSDS Cat.No.:{{item.cat}} {{index}} {{goods_show_value}} 
- 
                                    
                                    IF:{{item.impact}} Journal:{{item.journal}} ({{item.year}}) DOI:{{item.doi}}Reactivity:{{item.species}} Sample Type:{{item.organization}} 
- 
                                    Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}} 
 
                            

 
                